Literature DB >> 6982691

Determinants of operative survival following combined mitral valve replacement and coronary revascularization.

V J DiSesa, L H Cohn, J J Collins, J K Koster, S VanDevanter.   

Abstract

To determine the operative survival rate following combined mitral valve replacement (MVR) and coronary artery bypass graft (CABG) operation, we evaluated 100 patients, who were seen consecutively at the Peter Bent Brigham and Brigham and Women's Hospital from 1972 to 1982. There were 63 men and 37 women; the mean age was 62 years. Thirty-six patients were in New York Heart Association (NYHA) Functional Class III, and 64 were in functional Class IV. Mitral regurgitation was predominant in 76 patients; mitral stenosis, in 24. Emergency operations were performed in 15 patients, and elective or semielective operations were performed in 85. There were 18 operative deaths (18%): 9 in patients having elective operations (10.5%) and 9 in those having emergency operations (60%; p less than 0.01). Significant preoperative factors related to operative death were NYHA functional class, increased pulmonary vascular resistance, lower cardiac index, and lower ejection fraction in the nonsurvivors. The rate of survival did not differ according to sex, age, or degree of coronary artery disease. In addition, myocardial protection with potassium cardioplegia and complete coronary revascularization significantly reduced operative mortality in the elective group of patients but did not alter the mortality in the emergency group.

Entities:  

Mesh:

Year:  1982        PMID: 6982691     DOI: 10.1016/s0003-4975(10)62992-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Bypass graft material and myocardial protective procedure in combined coronary artery bypass grafting and valve surgery.

Authors:  H Fujii; H Otani; T Oka; Y Hino; H Fujiwara; T Sumida; M Osako; H Imamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-09

2.  Revascularization alone or combined with suture annuloplasty for ischemic mitral regurgitation. Evaluation by color Doppler echocardiography.

Authors:  L S Czer; G Maurer; A F Bolger; M DeRobertis; A Chaux; J M Matloff
Journal:  Tex Heart Inst J       Date:  1996

3.  Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements.

Authors:  L H Cohn; J J Collins; V J DiSesa; G S Couper; P S Peigh; W Kowalker; E Allred
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

4.  Surgical management of coexisting coronary artery and valvular heart disease.

Authors:  Sak Lee; Byung-Chul Chang; Kyung-Jong Yoo
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

5.  Routine electroencephalographic (EEG) monitoring during carotid endarterectomy.

Authors:  A D Whittemore; J L Kauffman; T R Kohler; J A Mannick
Journal:  Ann Surg       Date:  1983-06       Impact factor: 12.969

6.  Risk of combined coronary artery bypass and mitral valve replacement.

Authors:  S S Kabbani; T T Bashour; E S Hanna; D Ellertson
Journal:  Tex Heart Inst J       Date:  1984-12

7.  Rescue transventricular off-pump mitral valve repair with artificial neochords for acute mitral regurgitation due to postinfarction papillary muscle rupture.

Authors:  Mindaugas Budra; Vilius Janušauskas; Aleksejus Zorinas; Diana Zakarkaitė; Audrius Aidietis; Robertas Samalavičius; Kęstutis Ručinskas
Journal:  JTCVS Tech       Date:  2021-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.